Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis

Clinical management of gynecological cancer begins by optimal debulking with first-line platinum-based chemotherapy. However, in ~80% patients, ovarian cancer will recur and is lethal. Prognostic gene signature panel identifying platinum-resistance enables better patient stratification for precision...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunderson, Camille C, Radhakrishnan, Rangasudhagar, Gomathinayagam, Rohini, Husain, Sanam, Aravindan, Sheeja, Moore, Kathleen M, Dhanasekaran, Danny N, Jayaraman, Muralidharan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966103/
https://www.ncbi.nlm.nih.gov/pubmed/35370397
http://dx.doi.org/10.1177/11772719221088404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966103/
https://www.ncbi.nlm.nih.gov/pubmed/35370397
http://dx.doi.org/10.1177/11772719221088404

Ejemplares similares